MedPath

A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia

Not yet recruiting
Conditions
Endometrial Cancer
Endometrial Intraepithelial Neoplasia
Fertility-sparing Surgery
Registration Number
NCT06745427
Lead Sponsor
Region Stockholm
Brief Summary

We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia

Detailed Description

A multi-center prospective study on the oncological and reproductive outcomes and quality of life in young woman after fertility-sparing treatment of endometrial cancer and endometrial intraepithelial hyperplasia

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Fertility sparing treatment of EC and EIN.
  • 18-45 Years old
  • From start study (Jan 2025 - end study Jan 2028)
  • All centras in Sweden
Exclusion Criteria
  • Not English och Swedish speaking

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relaps of endometrial cancer or EIN after fertility-sparing treatmentfrom enrollment to 2 years after fertility-sparing treatment

Relaps of endometrial cancer or EIN after fertility-sparing treatment

Secondary Outcome Measures
NameTimeMethod
Live birth rate in women that has been treated with fertility-sparing treatment for EC or EINFrom start of study to 2 years after fertility-sparing treatment

Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN

© Copyright 2025. All Rights Reserved by MedPath